Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing solutions.
Patent CN109912569B reveals a mild, high-yield route for Esomeprazole Magnesium. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN109053637B details a high-yield route for chiral epoxy intermediates. Offers cost-effective scale-up for pest control manufacturers.
Patent CN105624128B reveals a robust immobilized enzyme process for synthesizing key HCV drug intermediates, offering superior stability and cost efficiency.
Patent CN107434802A details asymmetric oxidation for Esomeprazole sodium ensuring high purity and yield for reliable pharmaceutical intermediates supplier cost reduction.
Patent CN1298711C reveals a novel route for antifungal intermediates, eliminating protection steps for significant cost reduction and supply chain reliability.
Patent CN103570686B details high-purity Esomeprazole Sodium synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel asymmetric oxidation method ensures >99.5% purity. Reduces sulfone impurities. Reliable supply chain for global pharmaceutical manufacturers seeking cost-effective API solutions.
Patent CN105399728B reveals high-yield R-lansoprazole production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners globally.
Novel nickel-catalyzed route for (3Z,6Z,9S,10R)-9,10-epoxy-3,6-heneicosadiene offers scalable agrochemical manufacturing solutions.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.
Patent CN102807560A reveals asymmetric oxidation method. Achieves high purity and yield. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN121362155A reveals efficient iron-catalyzed sulfoxidation. Offers high ee, cost reduction, and scalable supply for pharma intermediates.
Patent CN116981659A details a novel Fe-catalyzed route for chiral sulfoxides, offering high purity and cost reduction in pharmaceutical intermediate manufacturing without chiral HPLC.
Novel catalytic oxidation process for S-omeprazole and analogs ensures high optical purity and simplified production workflow for global supply chains.
Patent CN106866630B reveals high-yield asymmetric oxidation for R-lansoprazole. Reduces impurities and enhances commercial scalability for pharmaceutical supply chains globally.
Novel enantioselective oxidation method using titanium-tartrate catalysts offers high purity and cost efficiency for proton pump inhibitor manufacturing.
Patent CN108623564B reveals a high-yield vanadium-catalyzed route for Dextro-Rabeprazole. Discover cost-effective manufacturing and superior enantioselectivity for your supply chain.
Patent CN114736882A discloses high-performance monoamine oxidase mutants for asymmetric oxidation, enabling cost reduction in API manufacturing and reliable supply.
Patent CN1106395C details a novel asymmetric synthesis for IBAT inhibitor intermediates, offering superior stereocontrol and scalable manufacturing for pharmaceutical supply chains.